Psychiatric considerations of multiple sclerosis
Keywords:
case report, multiple sclerosis, , psychiatric considerations, resistant depressionAbstract
Multiple sclerosis is a degenerative neuroinflammatory disease that affects the central nervous system with a wide range of neurological and psychiatric symptoms. A correct differential diagnosis is crucial for the management of pathology and there are specific diagnostic methods. This study presents the case of a 53-year-old patient diagnosed with Strumpell-Lorrain disease resistant to psychopharmacological treatment for depression and anxiety who, after the change of diagnosis and therapy to multiple sclerosis, showed clinical improvement in psychiatric symptoms.
Downloads
References
Alberte-Woodward, M., Soneira, J. N., & González, J. O. P. (2023). Multiple sclerosis: differential diagnosis and treatment. Medicine-Accredited Continuing Medical Education Program , 13 (78), 4628-4634. https://doi.org/10.1016/j.med.2023.04.011
Aryani, L. N. A., Ardjana, I. E., & Hanati, N. (2017). Emotion and behaviour disorders towards children of maternal depression in psychiatry polyclinic at RSUP Sanglah. International Research Journal of Engineering, IT and Scientific Research, 3(2), 139-149.
Brenner, P., & Piehl, F. (2016). Fatigue and depression in multiple sclerosis: pharmacological and non?pharmacological interventions. Acta Neurologica Scandinavica, 134, 47-54.
Charcot, J. (1868). Histology of multiple sclerosis. Gazette Hôpitaux , 41 , 554.
Chwastiak, L. A., & Ehde, D. M. (2007). Psychiatric issues in multiple sclerosis. Psychiatric Clinics of North America, 30(4), 803-817. https://doi.org/10.1016/j.psc.2007.07.003
Herman, H., Ardani, I. G. A. I., Aryani, L. N. A., Windiani, I. G. A. T., Adnyana, I. G. N. S., & Setiawati, Y. (2022). Signs and symptoms of depression in children and adolescents with type 1 diabetes mellitus: A case report. International Journal of Health and Medical Sciences, 5(1), 150-153.
Ko?tuniuk, A., & Rosi?czuk, J. (2021). The levels of depression, anxiety, acceptance of illness, and medication adherence in patients with multiple sclerosis-descriptive and correlational study. International journal of medical sciences, 18(1), 216.
Maier, H. B., Stadler, J., Deest-Gaubatz, S., Borlak, F., Türker, S. N., Konen, F. F., ... & Neyazi, A. (2024). The significance of cerebrospinal fluid analysis in the differential diagnosis of 564 psychiatric patients: Multiple sclerosis is more common than autoimmune-encephalitis. Psychiatry Research, 333, 115725. https://doi.org/10.1016/j.psychres.2024.115725
Maiese, K. (2023). Cognitive impairment in multiple sclerosis. Bioengineering, 10(7), 871.
Marrie, R. A., Zhang, L., Lix, L. M., Graff, L. A., Walker, J. R., Fisk, J. D., ... & Bernstein, C. N. (2018). The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Multiple sclerosis and related disorders, 20, 9-15. https://doi.org/10.1016/j.msard.2017.12.007
Moore, P., Hirst, C., Harding, K. E., Clarkson, H., Pickersgill, T. P., & Robertson, N. P. (2012). Multiple sclerosis relapses and depression. Journal of psychosomatic research, 73(4), 272-276. https://doi.org/10.1016/j.jpsychores.2012.08.004
Moreira, MA, Tilbery, CP, Lana-Peixoto, MA, Mendes, MF, Kaimen-Maciel, DR, & Callegaro, D. (2002). Historical aspects of multiple sclerosis. Rev neurol , 34 (4), 378-383.
Oh, J. (2022). Diagnosis of multiple sclerosis. CONTINUUM: Lifelong Learning in Neurology, 28(4), 1006-1024.
Palladino, R., Marrie, R. A., Majeed, A., & Chataway, J. (2020). Evaluating the risk of macrovascular events and mortality among people with multiple sclerosis in England. JAMA neurology, 77(7), 820-828.
Paparrigopoulos, T., Ferentinos, P., Kouzoupis, A., Koutsis, G., & Papadimitriou, G. N. (2010). The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. International review of psychiatry, 22(1), 14-21.
Peres, D. S., Rodrigues, P., Viero, F. T., Frare, J. M., Kudsi, S. Q., Meira, G. M., & Trevisan, G. (2022). Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: A systematic review and meta-analysis. Brain, behavior, & immunity-health, 24, 100484. https://doi.org/10.1016/j.bbih.2022.100484
Sá, M. J. (2008). Psychological aspects of multiple sclerosis. Clinical neurology and neurosurgery, 110(9), 868-877. https://doi.org/10.1016/j.clineuro.2007.10.001
Sabe, M., & Sentissi, O. (2022). Psychotic symptoms prior or concomitant to diagnosis of multiple sclerosis: a systematic review of case reports and case series. International Journal of Psychiatry in Clinical Practice, 26(3), 287-293.
Sarwer, D. B., & Fabricatore, A. N. (2008). Psychiatric considerations of the massive weight loss patient. Clinics in plastic surgery, 35(1), 1-10. https://doi.org/10.1016/j.cps.2007.08.006
Shanmugam, G., Bhutani, S., Khan, D. A., & Brown, E. S. (2007). Psychiatric considerations in pulmonary disease. Psychiatric Clinics of North America, 30(4), 761-780. https://doi.org/10.1016/j.psc.2007.07.008
Silveira, C., Guedes, R., Maia, D., Curral, R., & Coelho, R. (2019). Neuropsychiatric symptoms of multiple sclerosis: state of the art. Psychiatry investigation, 16(12), 877.
Solomon, A. J., Arrambide, G., Brownlee, W. J., Flanagan, E. P., Amato, M. P., Amezcua, L., ... & Cohen, J. A. (2023). Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. The Lancet Neurology, 22(8), 750-768.
Titus, H. E., Chen, Y., Podojil, J. R., Robinson, A. P., Balabanov, R., Popko, B., & Miller, S. D. (2020). Pre-clinical and clinical implications of “inside-out” vs.“outside-in” paradigms in multiple sclerosis etiopathogenesis. Frontiers in cellular neuroscience, 14, 599717.
Tobore, T. O. (2020). Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis. International journal of neuroscience, 130(3), 279-300.
Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., ... & Baneke, P. (2020). Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Multiple Sclerosis Journal, 26(14), 1816-1821.
Wildner, P., Stasio?ek, M., & Matysiak, M. (2020). Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. Multiple sclerosis and related disorders, 37, 101452. https://doi.org/10.1016/j.msard.2019.101452
Willumsen, J. S., Grytten, N., Aarseth, J., Myklebust, T. Å., Myhr, K. M., & Midgard, R. (2022). Mortality and cause of death in multiple sclerosis in western Norway 1950–2021: a registry-based linkage study. Journal of Neurology, Neurosurgery & Psychiatry, 93(11), 1154-1161.
Yusuf, F. L., Ng, B. C., Wijnands, J. M., Kingwell, E., Marrie, R. A., & Tremlett, H. (2020). A systematic review of morbidities suggestive of the multiple sclerosis prodrome. Expert Review of Neurotherapeutics, 20(8), 799-819.
Zhou, C., Peng, S., Lin, A., Jiang, A., Peng, Y., Gu, T., ... & Luo, P. (2023). Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database. EClinicalMedicine, 59.
Published
How to Cite
Issue
Section
Copyright (c) 2024 International journal of health & medical sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health & Medical Sciences (IJHMS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHMS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHMS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
